TY - JOUR
T1 - Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder
AU - Hudson, James I.
AU - Lalonde, Justine K.
AU - Coit, Caitlin E.
AU - Tsuang, Ming T.
AU - McElroy, Susan L.
AU - Crow, Scott J.
AU - Bulik, Cynthia M.
AU - Hudson, Margo S.
AU - Yanovski, Jack A.
AU - Rosenthal, Norman R.
AU - Pope, Harrison G.
PY - 2010/6/1
Y1 - 2010/6/1
N2 - Background: Binge-eating disorder may represent a risk factor for the metabolic syndrome. Objective: The objective was to assess longitudinally the relation between binge-eating disorder and components of the metabolic syndrome. Design: At 2.5 and 5 y of follow-up, 134 individuals with bingeeating disorder and 134 individuals with no history of eating disorders, who were frequency-matched for age, sex, and baseline body mass index (BMI), were interviewed during the follow-up interval regarding new diagnoses of 3 metabolic syndrome components: hypertension, dyslipidemia, and type 2 diabetes. Results: A comparison of individuals with and without a binge-eating disorder in analyses adjusted for age, sex, baseline BMI, and interval BMI change had hazard ratios (95% CIs) for reporting new diagnoses of metabolic syndrome components of 2.2 (1.2, 4.2; P = 0.023) for dyslipidemia, 1.5 (0.76, 2.9; P = 0.33) for hypertension, 1.6 (0.77, 3.9; P = 0.29) for type 2 diabetes, 1.7 (1.1, 2.6; P = 0.023) for any component, and 2.4 (1.1, 5.7; P = 0.038) for ≥2 components. Conclusion: Binge-eating disorder may confer a risk of components of the metabolic syndrome over and above the risk attributable to obesity alone. This trial was registered at www.clinicaltrials.gov as NCT00777634.
AB - Background: Binge-eating disorder may represent a risk factor for the metabolic syndrome. Objective: The objective was to assess longitudinally the relation between binge-eating disorder and components of the metabolic syndrome. Design: At 2.5 and 5 y of follow-up, 134 individuals with bingeeating disorder and 134 individuals with no history of eating disorders, who were frequency-matched for age, sex, and baseline body mass index (BMI), were interviewed during the follow-up interval regarding new diagnoses of 3 metabolic syndrome components: hypertension, dyslipidemia, and type 2 diabetes. Results: A comparison of individuals with and without a binge-eating disorder in analyses adjusted for age, sex, baseline BMI, and interval BMI change had hazard ratios (95% CIs) for reporting new diagnoses of metabolic syndrome components of 2.2 (1.2, 4.2; P = 0.023) for dyslipidemia, 1.5 (0.76, 2.9; P = 0.33) for hypertension, 1.6 (0.77, 3.9; P = 0.29) for type 2 diabetes, 1.7 (1.1, 2.6; P = 0.023) for any component, and 2.4 (1.1, 5.7; P = 0.038) for ≥2 components. Conclusion: Binge-eating disorder may confer a risk of components of the metabolic syndrome over and above the risk attributable to obesity alone. This trial was registered at www.clinicaltrials.gov as NCT00777634.
UR - http://www.scopus.com/inward/record.url?scp=77953077993&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953077993&partnerID=8YFLogxK
U2 - 10.3945/ajcn.2010.29203
DO - 10.3945/ajcn.2010.29203
M3 - Article
C2 - 20427731
AN - SCOPUS:77953077993
SN - 0002-9165
VL - 91
SP - 1568
EP - 1573
JO - American Journal of Clinical Nutrition
JF - American Journal of Clinical Nutrition
IS - 6
ER -